COMPARISON OF DOXORUBICIN CYCLOPHOSPHAMIDE VERSUS DOXORUBICIN/CYCLOPHOSPHAMIDE/TAMOXIFEN AND CMF-CHEMOTHERAPY VERSUS TAMOXIFEN IN NODE-POSITIVE BREAST-CANCER - AN UPDATE OF THE GERMAN ADJUVANT BREAST-CANCER GROUP (GABG) TRIAL/

Authors
KAUFMANN IM JONAT W VONMINCKWITZ G SCHMID H KLEINE W MELCHERT F ULMER MU STOSIEK U TRAMS G BALZER J CAFFIER H
Citation
Im. Kaufmann et al., COMPARISON OF DOXORUBICIN CYCLOPHOSPHAMIDE VERSUS DOXORUBICIN/CYCLOPHOSPHAMIDE/TAMOXIFEN AND CMF-CHEMOTHERAPY VERSUS TAMOXIFEN IN NODE-POSITIVE BREAST-CANCER - AN UPDATE OF THE GERMAN ADJUVANT BREAST-CANCER GROUP (GABG) TRIAL/, European journal of cancer, 34, 1998, pp. 82-82
Citations number
NO
Categorie Soggetti
Oncology
Journal title
European journal of cancer → ACNP
ISSN journal
09598049
Volume
34
Year of publication
1998
Supplement
1
Pages
82 - 82
Database
ISI
SICI code
0959-8049(1998)34:<82:CODCVD>2.0.ZU;2-Q